Switzerland
Companies
Swiss pharmaceutical giant Novartis is set to acquire an US$11bn stake in the ophthalmic group Alcon from Nestlé. Novartis has announced that it will acquire 25% of Alcon for US$143.18...
2008-04-08Industry
BMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound...
2008-03-25Industry
BMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound...
2008-03-25Industry
Switzerland's medical device market is highly developed and was worth approximately US$4.1bn in 2007. By 2012 the market should reach a value of US$5.2bn, representing a compound...
2008-03-13Industry
In response to the tough operating environment currently being experienced by multinational pharmaceutical companies, Swiss giant
2007-12-14Companies
Swiss drug giant Novartis has announced that it is to invest US$700mn in a new biotechnology manufacturing plant in Singapore.
2007-10-30Companies
Novartis - formed in 1996 through the merger of two Swiss drug firms Sandoz and Ceiba-Geigy - is the largest drugmaker in Switzerland, leading rival Roche by around US$5bn in annual...
2007-07-20
